連続的な毒性を使い第I相試験の最大耐用量を推定する

Phase I cancer trials seek the maximum tolerated dose (MTD) while protecting patients from excessive toxicity. Dose assignments must therefore balance patient safety with learning the dose--toxicity relationship as data accrue. We model continuously measured toxicity outcomes using two forms of Bayesian additive regression trees (BART): isotonic BART projects posterior response curves onto nondecreasing functions, whereas monotone BART constrains the model. Joint curve and variance draws induce an MTD posterior that guides dose selection through escalation with overdose control (EWOC). We compare these methods with three parametric procedures across seven dose--toxicity curves in simulation. We assess dose-limiting toxicity (DLT) counts, above-MTD assignments, signed last-dose error, and relative absolute error. The tree procedures attained the lowest mean RAE on four nonlinear curves and jointly minimized mean DLT counts and above-MTD assignments on four curves. A Bayesian reinforcement learning perspective formulates these sequential decisions as a finite-horizon planning problem. Dose restrictions yield a lower bound on last-dose error; under exact posterior-predictive evaluation, an EWOC-based rollout policy has no greater expected weighted loss than its baseline. Dose Trial Lab, a desktop simulator for all five procedures, accompanies the supplementary material.